In response to the letter “[11C]raclopride and extrastriatal binding to D2/3 receptors”
暂无分享,去创建一个
Pontus Plavén-Sigray | Simon Cervenka | Lars Farde | Martin Schain | Christer Halldin | Jonas Svensson | Mikael Tiger | Magdalena Nord | Johan Lundberg
[1] Christer Halldin,et al. Autoradiographic localization of extrastriatal D2‐dopamine receptors in the human brain using [125I]epidepride , 1996, Synapse.
[2] K. Glenk,et al. Validity and Reliability , 2008, Environmental Valuation with Discrete Choice Experiments.
[3] Marc Laruelle,et al. Evaluation of dopamine D2/3specific binding in the cerebellum for the positron emission tomography radiotracer [11C]FLB 457: Implications for measuring cortical dopamine release , 2011, Synapse.
[4] Christer Halldin,et al. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET , 2004, NeuroImage.
[5] Pontus Plavén-Sigray,et al. Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain , 2019 .
[6] Mark Slifstein,et al. Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride , 2008, Neuropsychopharmacology.
[7] Osama Mawlawi,et al. Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D2 Receptor Parameter Measurements in Ventral Striatum , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] C. Halldin,et al. Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man , 1995, Synapse.